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Abstract
Background: Nitric oxide (NO) is presumed to be a regulator of metamorphosis in many invertebrate species, and
although NO pathways have been comparatively well-investigated in gastropods, annelids and crustaceans, there
has been very limited research on the effects of NO on metamorphosis in bivalve shellfish.
Results: In this paper, we investigate the effects of NO pathway inhibitors and NO donors on metamorphosis
induction in larvae of the Pacific oyster, Crassostrea gigas. The nitric oxides synthase (NOS) inhibitors s-
methylisothiourea hemisulfate salt (SMIS), aminoguanidine hemisulfate salt (AGH) and 7-nitroindazole (7-NI) induced
metamorphosis at 75, 76 and 83% respectively, and operating in a concentration-dependent manner. Additional
induction of up to 54% resulted from exposures to 1H-[1,2,4]Oxadiazole[4,3-a]quinoxalin-1-one (ODQ), an inhibitor
of soluble guanylyl cyclase, with which NO interacts to catalyse the synthesis of cyclic guanosine monophosphate
(cGMP). Conversely, high concentrations of the NO donor sodium nitroprusside dihydrate in combination with
metamorphosis inducers epinephrine, MK-801 or SMIS, significantly decreased metamorphosis, although a potential
harmful effect of excessive NO unrelated to metamorphosis pathway cannot be excluded. Expression of CgNOS also
decreased in larvae after metamorphosis regardless of the inducers used, but intensified again post-metamorphosis
in spat. Fluorescent detection of NO in competent larvae with DAF-FM diacetate and localisation of the oyster nitric
oxide synthase CgNOS expression by in-situ hybridisation showed that NO occurs primarily in two key larval
structures, the velum and foot. cGMP was also detected in the foot using immunofluorescent assays, and is
potentially involved in the foot’s smooth muscle relaxation.
Conclusion: Together, these results suggest that the NO pathway acts as a negative regulator of metamorphosis in
Pacific oyster larvae, and that NO reduction induces metamorphosis by inhibiting swimming or crawling behaviour,
in conjunction with a cascade of additional neuroendocrine downstream responses.
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Background
A biphasic lifecycle is common in many aquatic inverte-
brate species, including a planktonic larval stage for dis-
persal and a sessile adult stage, with metamorphosis
marking the transition from one life stage to the other.
In bivalve species such as oysters, metamorphosis occurs
when swimming pediveliger larvae become ‘competent’,
wherein they sink to the bottom and begin searching for
an adequate surface to settle [1]. When environmental
cues meet requirements for a suitable settlement surface,
larvae undergo metamorphic changes, losing larval or-
gans such as velum and foot that allow them to swim or
crawl, and instead gain adult organs such as gills that
are better adapted to a sessile lifestyle; thus, entering
their juvenile stage, also known as spat. Complex neuro-
endocrine pathways and neurotransmitters have been
proposed as regulators for metamorphosis in bivalves
(reviewed in [2]), but there are many unknown factors
regulating this process. Recently, we provided evidence
for a previously unexplored regulatory pathway involved
in bivalve metamorphosis involving the transmembrane
N-Methyl-D-aspartate (NMDA) receptor [3–5]. As
ligand-gated and voltage-dependent ion channels,
NMDA receptors are located in synaptic cell membranes
and are activated by agonists, predominantly glutamate,
co-agonists (e.g. glycine) as well as the required dis-
lodgement of a magnesium ion block from the inner ion
pore by depolarisation of the cell membrane. The open-
ing of the receptors causes an inflow of Ca2+ leading to
an increase in the intracellular Ca2+ concentration,
which in turn generates downstream responses such as
activation of enzymes, gene regulation, or other cell-
specific responses (reviewed in [6]). We demonstrated
previously that exposure of competent larvae of different
oyster and clam species to MK-801, a NMDA receptor
specific channel blocker, significantly induced metamor-
phosis in these species [3]. Cloning and characterisation
of NMDA receptors in the Pacific oyster Crassostrea
gigas as well as localisation of NMDA receptor subunit
1, CgNR1, in key structures of competent larvae such as
the apical sensory organ (ASO), the underlying apical/
cerebral ganglia and the nerve network of the foot [5],
established the existence of functional NMDA receptors
in bivalve nervous systems. Both the ASO and the foot
are structures specific to larval stages, that disappear
after metamorphosis, which are assumed to be involved
in sensing the environment for settlement cues [7–9].
The ASO, in particular, is an organ that is present from
trochophore larval stage and persists in competent larvae
until just prior to metamorphosis in most aquatic
biphasic invertebrates. It is associated with sensory func-
tions and combines an apical tuft with long cilia, sensory
cells, and the apical and cerebral ganglia [10–12]. Based
on the combined findings of our previous work, it is
apparent that NMDA receptors are part of the regula-
tory mechanism of bivalve metamorphosis and more
specifically, that opening of NMDA receptors initiates
intracellular signalling and cells specific responses that
negatively regulate metamorphosis.
In vertebrates, NMDA receptor downstream responses
can be linked to the production of nitric oxide (NO) via
a Ca2+/calmodulin pathway with NMDA receptors regu-
lating the intracellular Ca2+ concentration. Calcium
functions as a second messenger and binds to calmodu-
lin, which subsequentially activates a nitric oxide
synthase (NOS). The NOS is the key enzyme in the pro-
duction of NO and catalyses L-arginine and NADPH to
L-citrulline, NO, and NADP. Despite this, information
on NO as a potential regulator of bivalve metamorphosis
is limited. A recent 2020 study on the hard-shelled
mussel, Mytilus coruscus, is the only known study in an-
other bivalve that has shown NOS inhibitors induce
metamorphosis, while NO donors inhibit the transform-
ation [13]. Furthermore, the mussel’s NOS expression
decreased in pediveliger larvae. This finding is not sur-
prising given that NO has also been suggested as nega-
tive regulator of metamorphosis in a wide range of other
biphasic invertebrates, including various gastropods [14–
19], polychaetes [20], barnacles [21, 22], sea urchins [23,
24], nudibranchs [25] and ascidians [26, 27]. Inhibition
of the NO pathway by exogenous NO scavengers or in-
hibitors to NOS has successfully induced metamorphosis
in these species. However, interestingly for some
gastropod, ascidian and sponge species, NO stimulated
metamorphosis instead [28–32], suggesting some
species-specific adaptation in response to NO [33].
Nevertheless, NO biosynthesis by NOS is a conserved
pathway, found in all types of living organisms from pro-
karyotes, plants to metazoans with a remarkable conser-
vation of animal NOS despite several duplication events
in invertebrates and vertebrates [34–36]. Nitric oxide
synthase expression and NO presence have been de-
tected prior to metamorphosis in larval organs and body
structures that are involved in sensing environmental
settlement cues (e.g. mouth and ASO), such as NOS
cells in the pharynx of annelid larvae [20], in the post
oral ciliary band and oral ganglion in sea urchins [23, 24,
37], in the ASO and apical ganglion of the snail
Ilyanassa obsoleta [17, 38, 39] and the foot of Haliotis
asinina [28], or in structures that disappear during phase
changes such as NO detection in tail regression of the
ascidian Ciona intestinalis [27]. Expression of NOS also
decreased in the snail I. obsoleta when metamorphosis
was induced [40], while in the abalone H. asinina, one of
the positively NO-regulated species, NOS expression
increased after induction [28]. Several theories have
emerged regarding NO downstream effects, inducing
metamorphosis including a NO-regulated activation of
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soluble guanylyl cyclase (sGC) converting guanosine
triphosphate (GTP) to cyclic guanosine monophosphate
(cGMP), which can lead to further downstream re-
sponses within cGMP-gated ion channels, phosphodies-
terases (PDEs), or protein kinases G (PKG) potentially
inhibiting metamorphosis [16, 21, 23, 25, 41]. Another
theory includes a negative regulation of apoptosis by NO
[17], with apoptosis being an important process during
metamorphosis leading to the loss of redundant larval
organs. Furthermore, in species with NO-inducing effect,
activation of the mitogen-activated protein kinase/extra-
cellular-signal-regulated kinase (MAPK/ERK) pathway
and subsequent regulation of metamorphosis-related
genes have been suggested [30–32].
Participation of NO pathways in regulating metamor-
phosis, however, has not been investigated in many bi-
valve species, although functional NOS homologs and
NO productions have been identified in the adult Pacific
oyster, C. gigas, [42] and other bivalve species [13, 43–
46]. Metamorphosis is a life stage transition charac-
terised by very high mortality rates in bivalves, under-
standing how metamorphosis is regulated, and can
quickly be induced, is important for several reasons.
First, it is important to the survival of natural bivalve
populations, as it allows for an understanding of the ef-
fects of environmental pollutants on key development
stages, but as such, could also assist in the development
of antifouling agents to prevent biofouling of unwanted
bivalve species. It is also important to increase spat pro-
duction in the aquaculture industry, where induction of
metamorphosis leads to better survival as well as syn-
chrony of cohorts during hatchery production. In this
paper, we provide the first evidence that the NO path-
way negatively regulates metamorphosis in the Pacific
oyster, C. gigas. We exposed competent oyster larvae to
various NOS inhibitors, to the sGC inhibitor 1H-[1,2,
4]Oxadiazole[4,3-a]quinoxalin-1-one (ODQ) as well as
to two NO donors in combination with known meta-
morphosis inducers. The gene expression profiles of
CgNOS in veliger larvae and after metamorphosis induc-
tion were analysed. Detection of NO in competent lar-
vae, localisation of CgNOS and CgNR1 expression in
competent and induced larvae and spat through in-situ
hybridisation, as well as the localisation of cGMP by im-
munofluorescent assay in larval histological sections and
whole-mount larvae, provides further information on the
potential role of the NO pathway to regulate bivalve
metamorphosis.
Results
Effect of NO pathway inhibitors and NO donors
Effects on metamorphosis induction of the specific NOS
inhibitors S-methylisothiourea hemisulfate (SMIS),
aminoguanidine hemisulfate (AGH), 7-nitroindazole (7-
NI), L-NG-nitroarginine methyl ester (L-NAME) L-NG-
nitroarginine (L-NNA) and the specific sGC inhibitor
ODQ were tested in 18 days post fertilisation (dpf) and
19 dpf competent Pacific oyster larvae, spawned in De-
cember 2018 (Fig. 1). Competence of larvae was verified
by exposing larvae to epinephrine (EPI) and MK-801 for
3 h at 10− 4 M, with both compounds resulting in induc-
tion percentages of 96.9 ± 0.6% for EPI and 62.1 ± 7.3%
for MK-801 in 18 dpf larvae, and 98.1 ± 0.4% for EPI and
81.0 ± 1.0% for MK-801 in 19 dpf larvae, respectively.
Metamorphosis in the non-treatment control was low
with 2.0 ± 2.0% when 18 dpf larvae used, but increased
with 19 dpf larvae to 13.4 ± 6.0%. For both experimental
sets, the DMSO controls did not significantly differ from
the non-treatment control.
Compared to the non-treatment control, significant in-
duction of metamorphosis was achieved in 18 dpf
competent larvae after 24 h continuous exposure to
SMIS, AGH and 7-NI at different concentrations with
most effective concentrations for SMIS at 10− 4 M with
75.1 ± 3.1%, for AGH at 10− 3 M with 75.9 ± 2.1% and 7-
NI at 10− 4 M with 83.0 ± 0.3% metamorphosis. The same
larvae set was also exposed to two additional NOS inhib-
itors, L-NAME and L-NNA, but both compounds did
not significantly induce metamorphosis. Similar results
were obtained when 19 dpf larvae were used with
significant induction of metamorphosis for SMIS, AGH
and 7-NI and no induction for L-NAME and L-NNA
(Additional file 1). The sGC inhibitor ODQ also induced
metamorphosis with most effective concentration of 5 ×
10− 5 M with 53.8 ± 5.2% in 19 dpf larvae. Metamor-
phosis induction was also achieved with ODQ in 18 dpf
larvae, but metamorphosis induction was less effective
and fewer concentrations without 5 × 10− 5 M was tested
(Additional file 1).
During exposure and final assessment of larvae and
spat, several noteworthy behaviour differences were ob-
served between treatments. During EPI and MK-801 ex-
posure larvae are generally immobile on the bottom, and
spat induced with EPI are unattached, while MK-801
spat are partially attached and unattached as previously
shown [3]. Some of those bottom laying larvae showed
visible contractions of the larval organs – a behaviour
often seen few hours after start of exposure to EPI, and
might suggest larvae were undergoing metamorphosis.
Spat, which metamorphosis was induced by exposing
them to SMIS, AGH and 7-NI were predominantly at-
tached to vial’s bottoms and sides. The appearance of
spat after AGH treatment, in particular, were subject-
ively smaller with less adult shell growth compared to all
other successful treatments. Interestingly, attachment of
animals to the surface appeared early in those treat-
ments. During sampling for the gene expression analysis,
larvae exposed to SMIS, AGH and 7-NI were
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predominantly stuck to the surface (‘stickiness’) with
those not-stuck either swimming or crawling. Larvae ex-
posed to ODQ were not attaching to the bottom, and
mostly and swimming or crawling instead. Only a small
fraction of spat was attached, similar to MK-801 spat. L-
NAME and L-NNA treated larvae were swimming and
crawling throughout exposure and did not differ in their
behaviour from the no-treatment control. DMSO con-
trol larvae were immobile on the bottom during expos-
ure and spat were either attached or unattached.
Effects of NO donors as metamorphosis inhibitor were
tested in co-exposures of larvae (18 dpf, March 2019)
with an inducer such as EPI, MK-801 or SMIS together
with a potential inhibitor, the NO donor 3-
morpholinosydnonimine (SIN-1) or sodium nitroprus-
side (SNP) for 3 h, followed by a continuous exposure to
the NO donor alone (Fig. 2). The NO donor SNP signifi-
cantly inhibited metamorphosis at concentrations of
10− 5 M and 10− 4 M, while the effect of SIN-1 did not
significantly decrease metamorphosis percentages com-
pared to inducers alone. Besides the reduction of spat in
the high concentration treatments of SNP, spat exposed
to SNP at 10− 4 M displayed limited adult shell growth
compared to single inducer exposed spat and remaining
larvae were immobile on the bottom.
Larvae, exposed to metamorphosis inducers, and sub-
sequent spat, were sampled for gene expression analysis
of a NOS homolog in Pacific oyster larvae. Larvae ex-
posed in January 2018 and March 2019 (Fig. 3A & B)
were successfully induced with EPI and MK-801 as well
as L-DOPA and ifenprodil (C. gigas 2018) and the NO
pathway inhibitors SMIS, AGH, 7-NI and ODQ (C. gigas
2019). Comparison between larval batches in December
2018 and March 2019 indicates that the responses to
NO pathway inducers were also cohort dependent, as we
have previously suggested for the NMDA receptor
Fig. 1 Percentage (%) of metamorphosis in Pacific oyster larvae after 24 h continuous exposure to single treatments (black bars) of NO pathways
inhibitors SMIS, AGH, 7-NI, L-NAME, L-NNA and ODQ, at different concentrations, as well as known inducers epinephrine (EPI; light grey bars) and
MK-801 (MK; grey bars) at 10− 4 M for 3 h, a DMSO (black-stripe bars) and a no treatment control (open bars). Data were collected 24 h post
exposure start. C. gigas larvae from December 2018 experiment with competent larvae 18 dpf were used for all treatments except for ODQ, for
which 19 dpf larvae were used. Error bars represent standard error. Different lower-case letters represent significant differences with p < 0.05
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related compounds, MK-801 and ifenprodil [3]. Experi-
ments conducted in March 2019 displayed lower meta-
morphosis percentages relative to experiments using
larvae from December 2018 (Fig. 1) for all inducers with
EPI with 81.3 ± 2.2%, MK-801 with 33.1 ± 1.7%, SMIS
with 46.1 ± 1.5%, AGH with 53.5 ± 0.9% and 7-NI with
32.9 ± 2.1% (Fig. 3B). Any age dependent effects based
on the fact that 18 dpf larvae were used in December
2018, and 17 dpf larvae in March 2019, could be ex-
cluded given that 18 dpf March 2019 larvae were also
tested (Additional File 2) and, although for some
compounds a higher metamorphosis percentage was
achieved (e.g. MK-801 with 47.3 ± 3.0% and 7-NI with
64.5 ± 1.8%), the metamorphosis induction was overall
lower compared to December 2018 experiments. Unfor-
tunately, exposure to ODQ did not significantly induce
metamorphosis in 17 dpf March 2019 larvae (4.1 ± 1.0%)
and 18 dpf exposed larvae/ spat were sampled for gene
expression analysis with metamorphosis induction of
18.1 ± 1.7% (Fig. 3B). However, results from ODQ sam-
ples should be interpreted with caution given that spat
appeared smaller in size compared to EPI or SMIS
Fig. 2 Percentage (%) of metamorphosis in Pacific oyster larvae after 24 h continuous exposure to single treatments (black bars) of NO donors
SIN-1 and SNP at 10− 6 M to 10− 4 M or as co-exposures (hashed bars) with epinephrine (Epi, light grey bars), MK-801 (MK, grey bars) and SMIS
(dark grey bars) at 10− 4 M for 3 h exposure followed by continuous single exposure to SIN-1 or SNP at 10− 6 M to 10− 4 M, and a non-treatment
control. Data were collected 24 h post exposure start. C. gigas larvae from March 2019 experiment with competent larvae 18 days post fertilisation
were used for all treatments. Error bars represent standard error. Different lower-case letters represent significant differences with p < 0.05
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treated animals and the DMSO control resulted in insig-
nificant comparable metamorphosis percentage with
25.1 ± 3.8% (Additional file 2). The effect of exposure
duration of NO pathway inhibitors was also tested in
March 2019, with larvae induced either for 3 h, 6 h or
24 h. However, no significant differences were observed
based on duration of exposure for SMIS, AGH, 7-NI and
ODQ exposed larvae (Additional file 2).
The specific gene translating CgNOS, the protein that
is suggested to produce NO in Pacific oysters, was
expressed at different late larval stages, during and after
exposure to metamorphosis inducers in competent pedi-
veliger larvae and in spat in both sample sets from 2018
and 2019 (Fig. 3C & D). In general, both experiments
showed comparable gene expression patterns for
CgNOS, independent of metamorphosis inducers or dif-
ference in early exposure sampling time. CgNOS gene
expression increased in pediveliger larvae around 16 dpf,
but decreased in older pediveliger larvae at 17 dpf in
2018 and 18 dpf in 2019. All inducers except ODQ af-
fected CgNOS gene expression in a similar trend with a
decrease in expression in 3 h post exposure start (hpe)
and 4 hpe larvae, followed mostly by a non-significant
weak expression increase in 6 hpe larvae. In spat, how-
ever, CgNOS gene expression increased significantly after
exposures to different metamorphosis inducers, except
for AGH. Naturally occurring control spat also increased
their expression of CgNOS compared to 18 dpf
competent larvae in 2018, suggesting that a rise in
CgNOS transcription in spat is a natural process inde-
pendent of inducers. In general, none of the inducers
displayed a unique pattern, with all inducers leading to a
comparable reduction of CgNOS gene expression during
metamorphosis, independently of any differences in the
percentages of larvae per treatment that were induced to
successfully undergo metamorphosis. One exception is
ODQ treated larvae and spat, which did not show any
differences in expression pattern up to 18 dpf competent
larvae. The reason for this is not clear, but might be due
to a side effect of the DMSO solvent and/or due to the
slow development based on the smaller size of ODQ
spat. A DMSO side effect was not observed in 7-NI
treated animals in larvae or spat appearance, but it can-
not be excluded.
Localisation of NO, NOS, NMDA receptor and cGMP
Nitric oxide was localised in competent larvae, in larvae
exposed for 3 h to EPI, MK-801, SMIS, AGH and 7-NI,
and in spat 24 hpe. Differences in NO position between
exposed and unexposed competent larvae were not de-
tected. However, differences in fluorescent NO signals
were observed depending on larvae displaying particular
behaviours such as swimming, crawling or laying immo-
bile on the bottom while displaying an organ pulsing
behaviour that suggests successful induction of meta-
morphosis (Fig. 4). In general, a NO signal was faintly
Fig. 3 Gene expression of CgNOS in Pacific oysters at different larval stages, larvae exposed to different metamorphosis inducers and spat 24 h
after metamorphosis induction as well as metamorphosis percentages (%) in Pacific oyster larvae after exposure to inducers. A & C) C. gigas
larvae, 18 dpf (d) in January 2018 experiments, exposed to epinephrine (EPI) and MK-801 (MK) at 10− 4 M, L-DOPA at 10− 5 M and ifenprodil (IP) at
10− 6 M and sampled at 4 hpe and 6 hpe. B & D) C. gigas larvae, 17 dpf or 18 dpf for ODQ in March 2019 experiments, exposed to EPI, MK-801,
SMIS and 7-NI at 10− 4 M, AGH at 10− 3 M and to ODQ at 5 × 10− 5 M and sampled 3 hpe and 6 hpe. S: spat, C: control spat. Error bars represent
standard error. Different lower-case letters represent significant differences with p < 0.05; *: significance not calculated due to differences in
sampling days
Vogeler et al. BMC Developmental Biology           (2020) 20:23 Page 6 of 18
visible in the intestine and rudimentary gills in most lar-
vae independent of behaviour. In swimming larvae, NO
signals were strongly detected in the velum (Fig. 4a & b),
particularly on the rim of the velum (Fig. 4c & d). The
foot and the apical tuft including the underlying ASO
and ganglia region did not display noticeable NO signals
(Fig. 4a & c), even when larvae were swimming with ex-
tended foot (Fig. 4b). The NO signal in the velum slowly
faded when larvae stopped swimming and rested on the
bottom. In crawling larvae actively searching the sub-
strate, on the other hand, detectable concentrations of
NO were predominantly in the foot, either the whole
foot (Fig. 4e & f) or only the tip (Fig. 4g). Larvae that
were displaying behaviour characteristic of successful in-
duction, such as laying immobile on the bottom with
visible contraction of larval organs, did not contain
detectable NO concentration in the velum or foot, but
NO was present in rudimentary gills and the intestine
(Fig. 4h). In spat, a NO signal was only visibly present in
the adult gills (Fig. 4j). Auto-fluorescent signals were not
observed in animals not exposed to DAF-FM diacetate
(Fig. 4k & l) with only a faint signal coming from the
rim of the larval shell.
Localisation of CgNOS gene expression by in-situ hy-
bridisation revealed a similar pattern as for the NO de-
tection in competent larvae. CgNOS is not differentially
expressed in untreated and treated larvae 3 hpe or 6 hpe
to EPI, but rather generally expressed in the two key lar-
val organs, the foot and the velum (Fig. 5). Transcripts
of CgNOS in the larval foot are detected towards the
base of the foot near the foot glands C, which seem to
be covered and/or partially penetrated (Fig. 5a & c). The
Fig. 4 Nitric oxide (NO) detection in competent Pacific oyster larvae and spat using the NO-specific fluorescent indicator DAF-FM diacetate.
Fluorescent and bright-field images of fluorescent NO signals in competent larvae swimming a left side view, b anterior view on foot, c ventral
view on velum, d ventral view on velum with visible apical sensory organ; in larvae with predominant foot crawling on the bottom e left side
view after AGH exposure, f anterior view and g left side view after MK-801 exposure; h larvae displaying organ contraction behaviour signalling
metamorphosis after EPI exposure; j spat 24 hpe to EPI; control animals without DAF-FM diacetate treatment k in competent larvae without
treatment and l spat hpe to EPI. aso: apical sensory organ, a.sh: adult shell growth, ci: cilia of the velum, f: foot, g: gills, gr: gill rudiments, l.sh:
larval shell growth, ve: velum, ve.r: rim of velum. Scale bar: 100 μm
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foot glands C together with foot glands D are presumed
to be involved in the production and secretion of the ad-
hesive that oysters produce to cement to the surface
during settlement [47–49]. CgNOS expression, however,
with its specific localisation near the foot base differs
from CgNR1, the gene that expresses NMDA receptor
subunit 1 CgNR1 and which is expressed in the nerve
network penetrating the whole foot starting from the
base of the foot towards the ciliated tip (Fig. 5b & d) [5].
Furthermore, CgNOS is not expressed in or near the ap-
ical/cerebral ganglia, as it has been shown previously for
CgNR1 [5]. Instead, CgNOS expression is located in the
velum membrane (Fig. 5e & f), which after unfolding,
forms the velum including a cilia band. Interestingly,
strong accumulation of CgNOS expression were not de-
tected in spat 24 hpe of EPI (Fig. 5g), although CgNOS
displayed higher expression levels in spat compared to
larvae treated with any of the metamorphosis inducers
(Fig. 3). Only faint signals were detected in the gills and
in structures in the visceral mass (white arrow heads,
Fig. 5g) as seen for larvae exposed to EPI (Fig. 5a). Fur-
thermore, no signals were detected in areas of the spat
section of what appears to be remnants of the larval foot.
Even though predominant adult shell growth as well as
adult gills are clearly visible in 24 h spat, often remnants
of the foot and occasionally velum are still present,
which have not yet been completely reabsorbed by the
animal after 24 h post metamorphosis. Complete loss of
larval organs can take 1 to 3 days depending on bivalve
species [50–53]. Fluorescent signals were also detected
along the pericostracum and occasionally on the edges
of the animals (stars Fig. 5). These signals are relics of
the Fast Red staining and were also observed in sections
incubated with the sense probe for CgNOS (non-specific
binding control), which did not display any signs for the
unspecific probe or Fast Red binding elsewhere in the
larval tissues sections (Additional file 3). No staining was
observed in the negative controls.
Spatial distribution of cGMP in larvae and spat by im-
munofluorescent labelling shows cGMP immunoreactiv-
ity in the foot of oyster larvae in whole-mount staining
(Fig. 6a, c, e) and tissue sections (Fig. 6b, d, f). The larvae
sections specifically show staining in ciliated foot includ-
ing the outer cell walls and in cell walls of large
Fig. 5 CgNOS (a, c, e-g) and CgNR1 (b, d) expression localisation in competent Pacific oyster larvae and spat by in-situ hybridisation using
digoxigenin labelled riboprobes (orange staining) with fluorescent signals visualised using a triple-band DAPI-FITC-Texas Red excitation filter.
Frontal serial sections of foot area of the same larva 6 hpe to EPI with (a) CgNOS and (b) CgNR1, both with subsequent H&E staining of sections.
Frontal sections of larvae (c) untreated with CgNOS and subsequent H&E staining of section, and (d) 6 hpe of EPI with CgNR1 and H&E staining of
consecutive section. Transverse section with CgNOS probe of competent larvae (e) untreated and (f) 6 hpe EPI treatment. (g) Sagittal section
whole spat and H&E staining of consecutive section. White arrows and arrow heads: signal for successful probe binding. aam: anterior adductor
muscle; ci: cilia of the velum; e: oesophagus; f: foot; fg C: foot glands C; fg D: foot glands D; g: gills; gr: gill rudiments; m: mantle; mo: mouth;
pam: posterior adductor muscle; pg: pedal ganglia; r. f: remnants foot; r. fg C: remnants foot glands C; vm: vellum membrane; *: Fast red dye
unspecific binding mostly in remains of periostracum. Scale bar: 50 μm
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individual cells within the foot tip. No signals were de-
tected in the pedal ganglia, foot glands C or D. Cyclic
guanosine monophosphate immunoreactivity in the foot
tip was generally observed across all larvae samples from
14 dpf to 17 dpf larvae 6 hpe EPI treatment (Fig. 6a-f,
Additional file 4). Positive signals were also observed in
spat when large foot remnants were visible (Fig. 6g & h),
but were absent when no visible foot remnants were de-
tected in whole-mount stained spat, or confined to a
very small foot remnant without foot tip in spat sagittal
sections (Fig. 6j & k). Additional weak signals were de-
tected around the stomach in sections of larvae (Fig. 6d)
and spat (Fig. 6h & k). Negative controls and non-
specific binding controls did not show significant immu-
noreactivity in larvae or spat near the ciliated foot area
during whole-mount staining or in sections (Add-
itional file 5). Western blot analysis confirmed anti-
cGMP polyclonal antibody (PAb) binding to oyster
larvae protein extracts, while no band was detected for
the negative control or for the anti-uNOS PAb, for
which no successful immunoreactivity during immuno-
fluorescent assay were obtained (Additional file 5).
Discussion
Successful induction of metamorphosis in Pacific oyster
larvae was achieved after exposure to the either of the
three NOS inhibitors SMIS, AGH or 7-NI, or to the
sGC inhibitor ODQ, providing the first evidence that the
NO pathway acts to inhibit metamorphosis in the Pacific
oyster, C. gigas. The inducing effect of these NO
Fig. 6 cGMP immunostaining in Pacific oyster larvae (a-f) and spat (g-k). Fluorescent and bright-field images of whole-mount stained individuals:
16 dpf larva (A, flattened with cover slip), 17 dpf larvae (c), 17 dpf larva 3 hpe EPI (e), spat with visible foot remnants (g), spat without visible foot
remnants (j); fluorescent images of sectioned individuals accompanied with superimposed DAPI/cGMP signals as well as H&E staining: transverse
section 17 dpf larva (b), sagittal section 17 dpf larva (d), frontal section 17 dpf larva 6hpe EPI (f), sagittal sections spat with large (h) and small
foot remnants (k). e: oesophagus; f: foot; fg C: foot glands C; fg D: foot glands D; g: gills; gr: gill rudiments; m: mantle; pam: posterior adductor
muscle; pg: pedal ganglia; r. f: remnants foot; r. fg C: remnants foot glands C; ve: velum. Scale bar: 50 μm
Vogeler et al. BMC Developmental Biology           (2020) 20:23 Page 9 of 18
pathway inhibitors, however, varies between larval co-
horts, thus confirming that the internal NO concentra-
tion is not the only factor regulating metamorphosis. In
addition to batch-related variability, which has also been
observed previously for other inducers of Pacific oysters
[3, 5] and other bivalve species [2], reported differences
in effectiveness of the NOS inhibitors might also be
caused by the binding specificity of each compound to
different NOS isozymes. SMIS is a relatively specific in-
hibitor of vertebrate inducible NOS (NOS II), while
AGH is an inhibitor of NOS II as well as vertebrate
neuronal NOS (NOS I), and 7-NI is advertised to inhibit
NOS I, although its binding selectivity has been
questioned [54]. Similar to many other invertebrates, the
Pacific oyster possesses one NOS homolog CgNOS [42],
without a linage specific duplication that occurs occa-
sionally in invertebrates, and is evidenced in several
other molluscan species [55–57]. While CgNOS displays
its highest sequence identity and structural similarities
with vertebrate NOS I [42], it is not a direct homolog to
either one of the two vertebrate NOSs or a third endo-
thelia NOS (NOS III). These three NOS homologs de-
rived from vertebrate-specific gene duplications [34–36].
Therefore, binding ability might vary, and could also ex-
plain the ineffectiveness in inducing metamorphosis of
some NOS inhibitors such as the inability of L-NAME, a
vertebrate non-selective NOS inhibitor, and L-NNA, se-
lective to NOS I and NOS III. While both compounds
have been successfully used to induce metamorphosis in
other invertebrates [18, 23, 25, 27], L-NAME in particu-
lar did not significantly decrease the NOS activity in the
scallop C. farreri while SMIS and spermidine trihy-
drochloride, another NOS I inhibitor, reduced its activity
[43]. L-NAME also did not induce metamorphosis in
annelids even at high concentrations [20]. However, L-
NAME induced metamorphosis in the hard-shelled
mussel [13] suggesting that inability to react to L-NAME
might not be a general bivalve trait. Further research is
needed to predict the binding ability of vertebrate NOS
inhibitors to CgNOS. It can also not be excluded that L-
NAME and L-NNA are not sufficiently taken up by
larvae and/or transported to the site of action in our ex-
periments given that bath applications with L-NAME in
the slipper snail Crepidula fornicata did not induce
metamorphosis [14, 58], while injection in the marine
snail I. obsoleta had an inducing effect [15, 16].
Our results further demonstrated that metamorphosis
induction was inhibited by the NO donor SNP after lar-
vae were induced with compounds associated with po-
tential regulatory pathways, including the adrenergic
pathway with EPI, the NMDA receptor pathway with
MK-801 and an NOS pathway with SMIS as NOS in-
hibitor. This could suggest that the NO pathway is re-
quired once an adrenergic or NMDA receptor pathway
is induced. However, this theory has to be evaluated with
caution. High concentrations of SNP were required to
inhibit metamorphosis. Therefore, a harmful effect of ex-
cessive NO cannot be excluded given that larvae were
immobile on the bottom of the vials and spat developed
poorly. Nitric oxide has been shown to have a wide
range of biological functions in marine invertebrates re-
lated to feeding, learning, defence and immune re-
sponses, as well as to environmental stress [59]. Nitric
oxide also inhibits gill respirations in adult bivalves [60,
61] and insufficient oxygen supply could potentially pro-
vide an unfavourable environment for metamorphosis
independent of the larva’s own internal NO-regulated
pathways. Inhibition of metamorphosis in other inverte-
brates has been mostly observed at high SNP concentra-
tion similar or higher to the concentration used in this
study [20–22]. Metamorphosis in the ascidian H.
momus, a positive NO-regulated species, was inhibited
by high concentrations of S-nitroso-N-acetyl-penicilla-
mine (SNAP), another commonly used NO donor, al-
though lower concentration significantly induced
metamorphosis [29], supporting a theory of a potentially
negative impact of excessive NO in bath applications un-
related to regulatory pathways involved in metamor-
phosis. Interestingly, the induction effect of AGH on
metamorphosis in M. corcurus mussels was significantly
inhibited by a 15 min exposure to two NO donors,
SNAP and SNP, and to L-arginine prior to the 24 h ex-
posure to AGH [13]. The authors concluded that
exposure to exogeneous NO can supress larval meta-
morphosis. However, a conclusive explanation on how
such short exposure to NO donor or L-arginine can in-
hibit metamorphosis for longer than 24 h, when an ef-
fective inducer is present, is still required.
Nevertheless, a reduction of NO production seems to
be required for successful induction and execution of
metamorphosis in C. gigas. This is supported by a de-
crease in CgNOS expression after induction of metamor-
phosis regardless of the inducer type. Decrease in NOS
expression during metamorphosis seems common in in-
vertebrate species whose metamorphosis is inhibited by
NO [27, 40], while upregulation of the NOS gene has
been reported in species which require NO for meta-
morphosis [29]. In the nudibranch Phestilla sibogae, a
species for which metamorphosis can be induced by NO
pathway inhibitors, NO production significantly de-
creased after induction of metamorphosis [25]. Yet, for
the slipper snail C. fornicata and the abalone H. asinina,
fluctuations of NOS expression during metamorphosis
have been described, suggesting that NOS expression
and subsequent NO production is not just either up or
downregulated throughout metamorphosis, but might
vary depending on metamorphosis progress, and could
also be affected by experimental conditions (e.g.
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handling stress, different rearing conditions) [28, 62],
which might also explain the minor differences in
CgNOS expression between the inducers.
Reduction in CgNOS expression during metamor-
phosis is likely to be related to its spatial expression.
CgNOS is predominately expressed in the velum mem-
brane as well as at the base of the foot, the two larval
organs that are lost during metamorphosis, which conse-
quentially leads to a decrease in CgNOS expression dur-
ing this process. However, both organs are crucial
during the larval life stage. As noted, CgNOS expression
increased during late larval development, at which time
the velum is growing and the foot developing (approx.
14–16 dpf). Increase in NOS expression has also been
reported in scallop C. farreri larvae with maximum ex-
pression in the late larval stage [43], but unfortunately,
no information was provided about CfNOS during meta-
morphosis. In the hard-shelled mussel, NOS expression
decreased in pediveliger compared to the earlier larval
stages, while the NOS activity in pediveliger increased
[13], suggesting that low expression does not always cor-
relate with low activity. Our results further show that
NO was present in the velum when oyster larvae were
swimming, and absent in the velum when resting on the
bottom. Crawling larvae displayed high NO concentra-
tions in the foot, but NO was not detected in the velum
or the foot when larvae displayed typical organ pulsing
behaviour, thus suggesting successful induction of meta-
morphosis. Inhibition of NOS and subsequent reduction
of NO by NOS inhibitors might therefore partially relate
to an impact on the swimming and crawling ability of
larvae, potentially signalling as substitution of a specific
environmental cue or imitating internal signals for ad-
equate conditions to initiate metamorphosis. Given that
metamorphosis was not induced in all larvae after expos-
ure to NOS inhibitors, additional prerequisite conditions
and pathways seem to be required to induce metamor-
phosis. Interestingly, expression of CgNOS increased
again in spat without strong spatial expression. The
DAF-FM diacetate assay localised NO predominately in
the gill. Faint signals of CgNOS expression were also de-
tected in the gills and in the visceral mass including the
stomach and the intestine. Nitric oxide synthase and
NO-ergic cells have previously been reported in gills, di-
gestive gland and intestine of adult bivalves [63–65],
suggesting the main function of NO in spat is around
respiration and digestion.
Upstream regulation and activation of NOS and the
NO pathway in Pacific oyster larvae are likely to be regu-
lated by Ca2+/calmodulin similar to vertebrate NOS [54]
as previously suggested for gastropod species [66, 67].
Moreover, intracellular Ca2+ concentrations might be
regulated by NMDA receptors. In adult snails L. stagna-
lis, an increase in NO production was achieved after
exposure to NMDA and glutamate, two NMDA receptor
agonists, and reversed by the NMDA receptor channel
blocker MK-801 [68]. Our study showed that in C. gigas
larvae CgNOS as well as CgNR1 are both expressed in
the foot, particularly near the foot base, supporting this
theory of NMDA receptor regulating NO production via
intracellular Ca2+ concentrations and subsequent activa-
tion of CgNOS. Co-localisation of NMDA receptors and
NOS in vertebrates mostly occur on the postsynaptic
side or neuromuscular junctions [69]. Thus, CgNOS
could receive signals from NMDA receptors for further
downstream pathways potentially involved in regulating
foot glands for cementation [47–49] or muscle fibres
([69], and references herein), both also located at the
base of the foot [47, 70]. Physical interaction between
vertebrate transmembrane NMDA receptors and NOS,
when not soluble in the cytosol, also exists via postsyn-
aptic density proteins 95 (PSD-95), which binds to the
PDZ domains of the NMDA receptor and NOS [71].
CgNOS have been shown to successfully interact with
CgPSD-95 [42] and C. gigas NMDA receptor sequence
analysis indicated PDZ domains [5]. The extended net-
work of NMDA receptor expressing cells from the base,
including foot glands D, and into the foot (this study
and [5]) might take part in forwarding internal signals or
responses to exogenous environmental cues received
from the tip to base of the foot. The foot of pediveliger
larvae have long been suggested as sensor of environ-
mental cues [8, 9]. In contrast, the ASO, the main larval
organ suspected of sensing environmental cues, did not
express CgNOS, and NO was not detected near the ap-
ical tuft or the underlying apical ganglia, although our
previous work has shown that the CgNR1 is expressed in
the apical/cerebral ganglia area [5]. Therefore, CgNOS
does not seem to be directly involved in responding to
environmental cues sensed by the ASO through an
NMDA receptor cascade. However, production of NO in
the velum membrane by CgNOS could still be regulated
by the ASO and underlying ganglia. In addition to
NMDA receptor presence, the apical/cerebral ganglia
complex consists of several serotonergic, acetylcholiner-
gic and FMRFamide reactive neurons, from which in
particular serotonin and acetylcholine neurites innervate
the ciliated velum [72], potentially interacting with
CgNOS and NO in the velum membrane and rim. Both
neurotransmitters have been previously linked to meta-
morphosis regulation in several bivalve species [2] and
other biphasic invertebrates [16, 19, 20, 73].
The cGMP presence in the foot concurred with NO
detection in the foot of crawling larvae as well as with
the NOS localised at the base of the foot, suggesting that
cGMP is part of the downstream NO pathway. Synthe-
sised NO at the base of the foot by NOS, which is trans-
ported or diffuses into the foot, activates the sGC to
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produce cGMP. Nitric oxide activating sGC and raising
intracellular cGMP concentration has also been sug-
gested for other invertebrate larvae [14, 23–25, 74]. The
presence of cGMP in all larval stages that have a devel-
oped foot further suggests that cGMP fulfils a more
generic function than exclusively being involved in regu-
lating metamorphosis induction. The cGMP interacts
with PKGs, which are involved in phosphorylation of
proteins leading to smooth muscle relaxation, with
cGMP present at basal levels, either free or bound to
PKGs or PDEs, the enzymes responsible for cGMP deg-
radation (reviewed in [75]). Investigations of myogenesis
in scallop Nodipecten nodosus larvae have shown that
the foot muscles consist of bundles of striated and
smooth muscle extending deep into the foot with foot
retractor muscles predominately made from smooth
muscles [76]. Thus, NO in C. gigas larvae might take
part in controlling the foot movements through contrac-
tion and relaxation of smooth muscles, with contractions
induced by calcium-regulated phosphorylation and re-
laxation regulated by cGMP, PKG and PDEs. Therefore,
potential environmental cues that stimulate or inhibit
endogenous NO production could regulate metamor-
phosis by keeping larvae either crawling or by impairing
foot movement, thereby signalling an adequate settling
surface. Regulation of smooth muscles by an NO/cGMP
pathway probably also occurs in the stomach and digest-
ive tract, which both have been shown to contain
smooth muscle tissue in bivalve larvae and juveniles [76,
77] and our results indicate a weak cGMP presence in
larvae as well as spat.
In contrast to the foot, cGMP was not detected in the
velum, although NO was detected in the velum of swim-
ming larvae, and CgNOS expressed in the velum mem-
brane. It is possible that NO-regulated movement of the
velum is not regulated by a NO/cGMP-pathway. This
theory is supported by studies on the velum retractor
muscles, which have been shown to be striated muscles
in larvae of the oyster C. gigas [70], mussels [77] and
scallops [76] with striated muscles being not regulated
by cGMP. Thus, the effect of NO on velum locomotion
might be implemented by an unknown effect on the cilia
movement given that NO is predominantly present in
the velum rim where the cilia are located. Differences in
muscle types, and the regulating pathways involved in
velum and foot movements, might also partially explain
the observed differences in induction success of the
three NOS inhibitors compared to ODQ, an sGC inhibi-
tor and the least effective inducer of oyster metamor-
phosis in this study. ODQ inhibits the production of
cGMP, consequently movement of the foot is impaired,
but the velum is not affected. If a resting state in both
organs is required for successful induction of metamor-
phosis, ODQ would only induce larvae whose velum had
also received a metamorphosis-inducing signal. In con-
trast, signals caused by the three NOS inhibitors are di-
rected to both the velum and the foot. The fact that spat
produced as a result of ODQ exposure were unattached,
also indicates that cGMP is not involved in the cementa-
tion process of the Pacific oyster. The fact that ODQ
produces mostly unattached spat while the three NOS
inhibitors produces mainly attached larvae and spat sug-
gests instead that attachment of larvae is regulated
downstream of the NOS and subsequent NO produc-
tion, but independent of the NO/cGMP pathway. It is
not clear yet how neuroendocrine pathways regulate the
cementation of oysters during settlement. Exposure ex-
periments with various neuro-active compounds either
produce attached or unattached spat; for instance, EPI
produces unattached spat, while L-DOPA causes attach-
ment (Bonar et al., [9]; Shpigel et al., [78]). However, fur-
ther research is needed to elaborate on how the NO
pathway is potentially involved in cementation.
The effect of NO on oyster larvae seems to be focused
on locomotion of larvae, with the presence of NO essen-
tial for swimming and crawling, while NO inhibition acts
as an inducer for metamorphosis. However, NO path-
ways might regulate additional downstream responses,
which should also be considered. Nitric oxide is an in-
hibitor of caspases [79], enzymes involved in regulating
and executing apoptosis [80]. Programmed cell death, of
which apoptosis is a form, has been detected in the ap-
ical ganglion of the snail I. obsoleta after metamorphosis
induction by NOS inhibitors and serotonin [19]. In C.
intestinalis, NO and caspase-3 regulate tail regression,
with inhibition of NO production resulting in an in-
crease in caspase-3 activity and acceleration of tail re-
sorption, while an increase in NO levels causes a delay
in this process [27]. Increases in caspase expression have
been reported during Pacific oyster metamorphosis [81],
and were localised in the velum and foot of Fujian oys-
ter, Crassostrea angulata, larvae after induction to EPI
[82]. The foot and velum are the two organs which in
competent C. gigas pediveliger larvae express CgNOS
and contain NO, as shown in our study. However, NO
downstream regulation of apoptosis varies depending on
concentration as well as cell type, given that NO can
have opposing effects as a pro- and anti-apoptotic ef-
fector [83]. NO-regulated apoptosis might also involve
several intermediate pathways including MAPK/ERK
and c-Jun NH2-terminal kinase JNK pathways as sug-
gested for ascidians and other biphasic invertebrates
[30–32, 84–86]. Additional research is needed to under-
stand if and how NO is involved in the apoptotic process
wherein the velum and foot are lost during oyster
metamorphosis.
In conclusion, NO is an essential negative regulator of
metamorphosis in the Pacific oyster with an apparent
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effect on the locomotive ability of larvae. Based on our
findings, we propose that NO detains larvae in the larval
stage by promoting a swimming and crawling behaviour.
When endogenous NO concentration decrease, either by
an internal signal or as a response to environmental
cues, swimming and crawling is impaired and larvae
proceed with metamorphosis. However, the inability of
NO pathway inhibitors to induce metamorphosis in all
larvae suggests that other currently unknown pathways
are also implicated. In addition to motility effects, other
effects of NO are possible and might include the in-
volvement of NO in regulating apoptosis, as well as the
cementation process. Nevertheless, our data provide
valuable new information about oyster metamorphosis
and emphasize the importance of NO pathways during
this key developmental stage of a bivalve species.
Methods
Chemical reagents
The catecholamine epinephrine hydrochloride (EPI), the
NOS inhibitors S-methylisothiourea hemisulfate salt
(SMIS) and aminoguanidine hemisulfate salt (AGH) as
well as the NO donor sodium nitroprusside dihydrate
(SNP) were purchased from Sigma-Aldrich. The irre-
versible inhibitor of soluble guanylyl cyclase 1H-[1,2,
4]Oxadiazole[4,3-a]quinoxalin-1-one (ODQ) and the NO
donor 3-morpholinosydnonimine chloride (SIN-1) were
obtained from AdipoGen Life Sciences and the NOS in-
hibitors L-NG-nitroarginine methyl ester (L-NAME)
hydrochloride, L-NG-nitroarginine (L-NNA) and 7-
nitroindazole (7-NI) were purchased from Cayman che-
micals. Additional chemicals were Levodopa (L-DOPA),
obtained from Santa Cruz Biotechnology, as well as
(+)-MK 801 maleate (MK-801) and Ifenprodil (+)-tar-
trate salt (ifenprodil), both obtained from Selleckchem.
Stock solutions at 10− 1 M for SMIS, AGH and SNP or
at 10− 2 M for remaining compounds were either pre-
pared with autoclaved Milli-Q dH2O or with DMSO
(Sigma-Aldrich) for 7-NI and ODQ. Working solutions
(10x concentrate of final concentration of treatment) for
each compound were prepared prior to experiments
with 1 μm filtered fresh seawater (FSW).
Animal husbandry and metamorphosis assay
Pacific oysters, C. gigas, were cultured at the South Aus-
tralian Research and Development Institute in Adelaide,
South Australia with larvae derived from several inde-
pendent spawning events were used for experiments.
Larvae from nine family lines were obtained from the se-
lective breeding program in January 2018 (C. gigas 2018)
and are described in [5]; larvae from six females and
nine males were similarly obtained 12 months later in
December 2018, and finally larvae from 19 family lines
in March 2019 (C. gigas 2019). All larvae were reared in
FSW, maintained at 24.5 ± 0.5 °C with a salinity of
36.5 ± 0.5 ppt and fed with a microalgal mixture of Tiso-
chrysis lutea, Pavlova lutheri, Chaetoceros calcitrans and
Chaetoceros muelleri.
All metamorphosis assays were conducted following a
general protocol as previously described [3–5]. In brief,
competent pediveliger larvae (shell length 300–330 μm,
visible eyespot, crawling behaviour) were placed in FSW
in glass shell vials using a pipet with a large tip opening,
continuously exposed to chemical compounds for either
1 h, 3 h, 6 h or 24 h; the chemicals were then removed by
pipetting, and 10 ml FSW including microalgae was
added to each vial. For the 24 h continuous exposures,
the microalgal mixture was added to the vials at the be-
ginning of exposures as a proportion of the total volume
of 10 ml in the vial. Differences in total FSW volumes
during exposure were necessary in order to provide suf-
ficient water volume to maintain an appropriate environ-
ment for the duration of exposure, while keeping
chemical usage, costs and chemical waste to a minimum.
Final chemical concentrations for exposure experiments
for EPI and L-DOPA were based on Bonar et al. [9] and
for MK-801 and ifenprodil based on Vogeler et al. [3, 4].
For compounds previously not used on C. gigas larvae, a
dose-range was used at which most known settlement
inducers for bivalves are operating. Controls, including a
no-treatment control, as well as a DMSO control with
maximum volume of DMSO equal to the highest volume
solvent in working solutions were used. After 24 h, ani-
mals were assessed under an inverted microscope and
early spat, live and dead larvae were counted. Mortality
percentages varied from 0 to 7.6% in individual vials
after 24 h, but did not differ significantly between
treatments.
NO inhibitor and donor experiments - (A) Single ex-
posures: approximately 80–115 larvae (December 2018;
18 dpf & 19 dpf) were exposed to EPI and MK-801 at
10− 4 M for 3 h in a total volume of 2.5 ml, and to SMIS,
AGH, 7-NI, ODQ, L-NAME and L-NNA for 24 h con-
tinuously at final concentrations ranging from 10− 7 M to
10− 3 M. (B) Co-exposures: approximately 90–120 larvae
(March 2019; 18 dpf) were exposed to single treatments
of EPI, MK-801 and SMIS at 10− 4 M for 3 h in a volume
of 2.5 ml, and to SIN-1 and SNP at 10− 6 M to 10− 4 M
for 24 h continuously, as well as to co-treatments with
either EPI, MK-801 or SMIS at 10− 4 M together with
either SNP or SIN-1 at 10− 6 M to 10− 4 M for 3 h in a
volume of 2.5 ml with a subsequent single exposure to
either SNP or SIN-1 for the remaining 21 h continuously
in a total volume of 10 ml.
NOS gene expression experiments – (A) C. gigas 2018:
approximately 250–320 larvae (January 2018, 18 dpf)
were exposed to EPI at 10− 4 M for 1 h, and to MK-801
at 10− 4 M, L-DOPA at 10− 5 M and ifenprodil at 10− 6 M
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for 3 h in a total volume of 2.5 ml as previously de-
scribed in [5]. The larvae were either sampled at 4 hpe
and 6 hpe as well as spat 24 hpe for further analysis, or
kept in the vials for 24 h and assessed under an inverted
microscope. (B) C. gigas 2019: approximately 250–320
larvae (March 2019, 17 dpf & 18 dpf) were exposed to
EPI and MK-801 at 10− 4 M for 3 h in a volume of 2.5
ml, as well as to SMIS and 7-NI at 10− 4 M, AGH at
10− 3 M and ODQ at 5 × 10− 5 M for either 3 h or 6 h in
a total volume of 5 ml, or for 24 h continuously. Larvae
were either sampled at 3 hpe, 6 hpe or as spat 24 hpe or
kept for 24 h assessment of metamorphosis. Larvae and
spat attached to glass vials were gently detached with a
sharp spatula. Three separate samples were taken at
each sampling point with each sample consisting of
three biological replicates.
Gene expression analysis
C. gigas larvae of different developmental larval stages,
larvae after exposure to metamorphosis inducers, as well
as spat were analysed for the gene expression study: C.
gigas 2018 animals at mid-veliger (9 dpf), late veliger (14
dpf), pediveliger larvae (16 dpf), competent pediveliger
larvae (17 dpf & 18 dpf), larvae exposed to EPI, L-
DOPA, MK-801 and ifenprodil at 4 hpe, 6 hpe and spat
24 hpe, were preserved in RNAlater (Sigma-Aldrich); C.
gigas 2019 animals at 14 dpf − 18 dpf, larvae exposed to
SMIS, 7-NI, AGH and ODQ at 3 hpe, 6 hpe and spat at
24 hpe, were preserved in PaxGene Tissue system
(PreAnalytix).
An NOS homolog, CgNOS (GenBank ID: XM_
011421861), was identified in the Pacific oyster genome
(ASM29789v2, Annotation Release 101 [87]) by a
tBLASTn search using protein sequences to human
nNOS (GenBank ID: AAA36376), eNOS (GenBank ID:
AAA36364) and iNOS (GenBank ID: AAA59171). A pri-
mer pair for CgNOS with an amplicon length of 185 bp
was designed with Primer Blast at NCBI [88]: forward
primer 5′-GAAGATGACCTCGGAGCAGG-3′, reverse
primer 5′-TGACCACTTCATCAGTCCGC-3′. Relative
gene expression for CgNOS was assessed for all samples
using quantitative PCR based on a modified comparative
Ct model [89] following the protocol as previously de-
scribed with the elongation factor-1 α, ribosomal protein
S18, ribosomal protein L7 as reference genes [5]. Total
RNA was extracted from developmental stages (~ 35–40
mg), exposed larvae (~ 600 larvae) and spat (100–600
spat depending on metamorphosis success) using TRI
Reagent RNA Isolation Reagent (Sigma-Aldrich) follow-
ing the manufacturer’s protocol. The amount of cDNA
template was 0.5 μg in 2018 experiments and 1 μg in
2019 experiments. Optimal primer efficiency for CgNOS
was reached at an annealing temperature of 62 °C and a
final primer concentration of 0.2 μM.
DAF-FM diacetate assay
For NO detection in competent Pacific oyster larvae,
eyed pediveliger larvae (derived from two males and two
females) were obtained from the Roem van Yerseke
hatchery in Yerseke, the Netherlands, and held at 23 °C
in 100 L static tanks at the Ghent University in UV
treated FSW with salinity and pH of 33.5 ± 0.5 ppt and
pH 8.1 ± 0.1, respectively. Larvae were fed daily after
daily water change with a microalgal mixture (1:1:2) of
T. lutea, C. muelleri and P. lutheri.
Nitric oxide in oyster larvae was detected using the 4-
amino-5-methylamino-2′,7′- difluorofluorescein (DAF-
FM) diacetate, a non-fluorescent, cell-permeant
compound that after hydrolysis to DAF-FM, reacts with
NO to produce a relatively impermeable fluorescent tria-
zolofluorescein derivative. Twenty to fifty competent lar-
vae (24–26 dpf, 290–310 μm) were placed a 12 well plate
in a total volume of 2.5 ml FSW, untreated or exposed
to EPI, MK-801, SMIS and 7NI at 10− 4 M or AGH at
10− 3 M for 3 h, chemicals were then removed and 5ml
of FSW with microalgal feed was added to each well.
Stock solution of 5 mM DAF-FM diacetate (Sigma Al-
drich) was prepared with DMSO (Sigma-Aldrich) a few
days prior to experiments and stored at − 20 °C until
usage. After 1 h, water was changed again without
microalgal feed and larvae were exposed to a final con-
centration of 7.5 μM DAF-FM diacetate in 2 ml FSW for
60min in the dark. Spat from a previous day exposure
to EPI were also incubated with 7.5 μM DAF-FM diace-
tate. Animals were washed twice with 1 ml FSW and
incubated for 30 min in 2 ml FSW to allow complete de-
esterification of intracellular diacetates. Animals were
assessed alive using a Zeiss Axioskop 2 plus fluorescent
microscope equipped with a FLUO filter set 38 (Ex:
470 ± 40 BP, Em: 525 ± 50 BP;) and pictures were taken
using a monochrome Retiga3 Camera (QImaging) with
Ocular V 2.0 Software (Digital Optics Limited) for
imaging. To aid taking pictures of swimming larvae, ani-
mals were occasional anaesthetised with 7.5% MgCl2 in
FSW. Animals not exposed to DAF-FM diacetate were
also assessed, but exhibited only very weak fluorescence
at the wavelength employed.
In-situ hybridisation
Gene expression of CgNOS and CgNR1 were localised in
pediveliger larvae by in-situ hybridisation (ISH). Compe-
tent larvae, untreated 17 dpf and 3 hpe of EPI, as well as
spat 24 hpe of EPI from the March 2019 spawning event
were anaesthetised with 7.5% MgCl2 in FSW prior fixing
in PaxGene Tissue system (PreAnalytix). Sectioning of
larvae and execution of ISH followed the protocol previ-
ously described [5]. Riboprobes were produced from
cDNA fragments from CgNOS (344 bp) and CgNR1 (323
bp). Antisense riboprobes for DIG labelling were
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generated with specific forward primers and reverse
primers with a T7 antisense extension for CgNOS
(forward primer 5′-GGAATGTGGGACGTGTTGCC-
3′, reverse primer + T7 extension 5′-TAATACGACT
CACTATAGGGGCTCGGTCCTTCCACAGTGA-3′) and
CgNR1 (forward primer 5′-TGCAACTGGGACAAGA
ACGA-3′, reverse primer + T7 extension 5′- TAATACGA
CTCACTATAGGGTGCAACTGGGACAAGAACGA-3′)
by PCR using MyTag PCR mix (Bioline) at 95 °C for 1min,
35 cycles of 95 °C for 15 s, 65 °C (CgNOS) or 64 °C (CgNR1)
for 15 s and 72 °C for 30 s with a final extension of 2min at
72 °C. Sense riboprobes for CgNOS used as non-specific
binding control in the ISH assay were amplified using the
specific forward primer with a T7 sense extension and the
reverse primer during the PCR. DIG labelling of all probes
was conducted using the DIG RNA labelling kit (Roche)
using an RNA T7 polymerase. After successful hybridisa-
tion, sections were mounted using a Vectamount (Vector
Laboratories) and examined and photographed using an
epi-fluorescent Arcturus XT Laser Capture Microdissection
system (ThermoFisher Scientific) build on a Nikon Eclipse
Ti-E microscope with triple-band DAPI-FITC-Texas Red
excitation filter and a QImaging MicroPublisher Color
RTV-5.0 CCD Camera (QImaging Corp.) for imaging.
Additional conventional hematoxylin and eosin (H&E)
staining was performed for anatomy identification with
the sections used for sense probes of CgNOS or CgNR1
after removal of Vectamount. Unfortunately, some indi-
viduals on sections were lost during this procedure and
consecutive H&E stained section were used instead.
Immunofluorescent assay
For localisation of cGMP in larva, immunofluorescent
assays were carried out using a rabbit anti-cGMP poly-
clonal antibody PAb (Sigma-Aldrich, 09–101) on sec-
tions of larvae and in whole mount. Before fixation
larvae were relaxed with 7.5% MgCl2 and then fixed in
PaxGene Tissue system (PreAnalytix).
Sections of competent larvae were prepared as for the
ISH analysis previously described [5]. Sections were
dewaxed in xylene for 2 × 5min and gradually rehy-
drated through graded alcohol bath with 100% ethanol
followed by 70% ethanol, each for 5 min, and a final 5
min bath in 1x PBS (0.02M phosphate, 0.15M NaCl,
pH 7.1). Sections were washed in 1xPTA (PBS + 4%
Triton X-100 (Sigma-Aldrich)) for 10 min and then pre-
treated with blocking buffer (5% goat serum in 1xPTA)
for 45 min in the dark. Blocking buffer was removed and
sections were incubated overnight in the dark at 4 °C in
blocking buffer with primary antibodies, either 1:500
anti-cGMP PAb or 1:200 rabbit anti-Salmonid MHC II
PAb (Vertebrate Antibodies Ltd., UK) as rabbit antibody
control for non-specific binding, or without a primary
antibody functioning as control for non-specific
secondary antibody control (Additional file 5). Sections
were washed three times with 1xPTA for 10min and
then incubated for 2 h in the dark in blocking buffer
with 1:100 secondary antibody Goat anti-Rabbit IgG
(H + L) Cross-Adsorbed Secondary Antibody DyLight
550 (Invitrogen, SA5–10033). Slides were rinsed three
times with 1xPTA for 10 min.
For whole-mount localisation of cGMP, larvae were
decalcified in 10% EDTA in 1xPBS for 5 h, washed with
1xPBS for 5 min and 1xPTA for 10min and then incu-
bated for 24 h at 4 °C with blocking buffer. Next, larvae
were incubated with primary antibody as above and in-
cubated for 45–48 h in the dark at 4 °C with occasional
shaking. Larvae were then washed three times over a
period of 5 h in the dark on a shaking plate and then in-
cubated for 21–24 h at 4 °C in the dark with the second-
ary antibody. After incubation, larvae were washed twice
for 1 h in the dark on a rocking platform.
Section and individual whole larvae were mounted
using Vectashield Antifade Mounting Medium with
DAPI (Vector Laboratories) and were examined and
photographed using an epi-fluorescent Arcturus XT
Laser Capture Microdissection system (ThermoFisher
Scientific) built on a Nikon Eclipse Ti-E microscope with
G-2A filter for the DyLight 550 secondary antibody and
UV-2A filter for the DAPI staining. An additional con-
ventional H&E staining of a section was performed for
anatomy identification after mounting medium was
removed.
In addition to the ISH detection of CgNOS, an im-
munofluorescent assay was performed using a universal
uNOS polyclonal antibody (PA1–38835, Invitrogen) at 1:
100 and 1:200 dilutions in larval section and whole-
mount larvae samples, but successful binding could not
be obtained, not recommending this antibody for NOS
detection in the Pacific oyster (Additional file 5).
A Western blot analysis was conducted to confirm
successful binding of anti-cGMP PAb to oyster larvae
protein. Thirty milligrams of 17 dpf oyster larvae were
homogenized in 0.5 ml 1xPBS using a bead beater. The
supernatant was aliquoted and protein concentration
was quantified using a Pierce BCA Protein Assay Kit
(ThermoScientific) following the manufacture’s protocol.
Undiluted protein extracts were diluted 4:1 with 5x so-
dium dodecyl sulphate (SDS) sample buffer (0.5 M Tris–
HCl, pH 6.8, 20% glycerol, 4% SDS, 0.2M dithiothreitol,
0.02% bromophenol blue), boiled for 10 min and centri-
fuged for 2 min at 16,000 g. Fifteen microliter of pre-
pared samples were loaded into a 10% Mini-PROTEAN
TGX Precast Gel (Bio-Rad, UK) and subjected to SDS
polyacrylamide gel electrophoresis (SDS-PAGE). Pro-
teins were then electro-transferred to a nitro-cellulose
membranes (Amersham Hybond ECL, GE Healthcare)
using a Pierce G2 Fast blotter (ThermoScientific) for 7
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min at 25 V. Membrane was blocked with 3% skimmed
milk powder (SMP) in tris buffer saline (TBS, 0.02M
Trisma base, 0.5M NaCl, pH 7.5) overnight at 4 °C.
Membranes were then washed three times in TBST
(TBS + 0.05% Teeen20) for 5 min and cut into strips.
The membrane strips were individually incubated in 1:
500 anti-cGMP PAB, 1:100 anti-uNOS PAB or without
antibody (negative control) in TBS + 1% SMP for 2 h at
RT and washed three times in TBST. Membranes were
then incubated again with anti-rabbit IgG Peroxidase
Conjugate (Sigma Aldrich) diluted 1:250 in TBS + 1%
SMP for 1 h at RT. After a final wash with TBS positive
bands showing antigen-PAb complexes in the membrane
were developed with ImmPact DAB Peroxide Substrate
Peroxidase (Vector Laboratories) following the manufac-
turer’s instructions.
Data analysis
Metamorphosis success was calculated as percentages of
larvae completing metamorphosis based on the total num-
ber of individuals in each vial presenting the average and
standard error of three biological replicates per treatment.
The non-parametric Kruskal–Wallis H-test was applied to
analyse the effects between different treatments, followed
by pairwise comparison using a generalisation of the Dun-
nett’s T3 method to trimmed means [90].
The gene expression patterns of all genes were ana-
lysed for three independent replicates for each sampling
point using a one-way ANOVA follows by multiple pair-
wise comparisons using a Tukey’s Honestly Significant
Difference Test. All statistical tests were run using the R
software (R version 3.5.1) and the probability level of
0.05 was chosen as being significant.
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